Imperial College London
Portrait Picture

ProfessorNagyHabib

Faculty of Medicine, Department of Surgery & Cancer

Professor of Hepatobiliary Surgery
 
 
 
//

Contact

 

+44 (0)20 3313 8574nagy.habib

 
 
//

Assistant

 

Mrs Benita White +44 (0)7960 986 387

 
//

Location

 

BN1/18 B BlockHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Banerjee:2012:10.2147/VHRM.S25745,
author = {Banerjee, S and Williamson, DA and Habib, N and Chataway, J},
doi = {10.2147/VHRM.S25745},
journal = {Vasc Health Risk Manag},
pages = {569--580},
title = {The potential benefit of stem cell therapy after stroke: an update.},
url = {http://dx.doi.org/10.2147/VHRM.S25745},
volume = {8},
year = {2012}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future.
AU  - Banerjee,S
AU  - Williamson,DA
AU  - Habib,N
AU  - Chataway,J
DO  - 10.2147/VHRM.S25745
EP  - 580
PY  - 2012///
SP  - 569
TI  - The potential benefit of stem cell therapy after stroke: an update.
T2  - Vasc Health Risk Manag
UR  - http://dx.doi.org/10.2147/VHRM.S25745
UR  - https://www.ncbi.nlm.nih.gov/pubmed/23091389
UR  - http://hdl.handle.net/10044/1/45678
VL  - 8
ER  -
Download